ClearOne is trading 10.98% up at $4.65 after Vivani Medical announced on September 16, 2026, that pricing and closing of its previously announced Cortigent merger with ClearOne are expected in October 2026.
- The transaction would make Cortigent a wholly owned subsidiary of ClearOne.
- It represents the clearest company-specific catalyst for the pre-market move.
- Broader markets are also higher, but the merger timeline is the primary driver.